Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
FEMY is expected to report earnings to fall 5.00% to -9 cents per share on March 26
Q4'25
Est.
$-0.09
Q3'25
Beat
by $0.03
Q2'25
Est.
$-0.16
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.04
The last earnings report on November 14 showed earnings per share of -10 cents, beating the estimate of -12 cents. With 715.12K shares outstanding, the current market capitalization sits at 57.92M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FEMY showed earnings on November 14, 2025. You can read more about the earnings report here.